Fuyuan Pharmaceutical announced that the 9th meeting of the third board of directors of the company deliberated and passed two proposals: one is to use no less than 80 million yuan and no more than 100 million yuan of its own capital to repurchase shares through centralized bidding transactions for equity incentives or employee stock ownership plans. The repurchase price is no more than 23.54 yuan/share, and the repurchase period is within 12 months from the date of review and approval by the board of directors; second, it plans to invest in the construction of a pharmaceutical design center project, with a project investment of about 198 million yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.